Drug Shortage Report for TOMUDEX

Last updated on 2018-10-13 History
Report ID 60044
Drug Identification Number 02229566
Brand name TOMUDEX
Common or Proper name TOMUDEX
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) RALTITREXED
Strength(s) 2MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 x 2mg GVL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-18
Estimated end date
Actual end date 2018-10-12
Shortage status Resolved
Updated date 2018-10-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2018-10-13 English Compare
v14 2018-10-12 French Compare
v13 2018-10-12 English Compare
v12 2018-10-10 French Compare
v11 2018-10-10 English Compare
v10 2018-10-10 French Compare
v9 2018-10-10 English Compare
v8 2018-10-04 French Compare
v7 2018-10-04 English Compare
v6 2018-09-26 French Compare
v5 2018-09-26 English Compare
v4 2018-09-19 English Compare
v3 2018-09-06 French Compare
v2 2018-09-06 English Compare
v1 2018-09-06 English Compare

Showing 1 to 15 of 15